retatrutide clinical trials south africa SA regulators battle to stem tide of illicit weight loss jabs Triple hormone receptor agonist retatrutide

GLP-1-related nausea and vomiting often follow a predictable patterntypically occurring after injections, especially during dose increases and gradually improving over time

Ahmed, Ahmed A

doi: 10.3390/brainsci15050480 51 FontanellaRAGhoshPPesapaneATaktazFPuocciAFranzeseMet al

CrossRef Classification of intestinal inflammation driven by gut microbiota metabolites: a new paradigm for precision treatment of cardiovascular diseases Dahua Zhao, Yanjun Cui, Zhen Hua Frontiers in Microbiology .2026;[Epub] CrossRef Bile Acids and the GutX Axis: TCM-Mediated Systemic Protection and Therapeutic Opportunities for Multi-Organ Diseases Jialu He, Linjie Qin, Xian Sun Metabolites .2026

At AgeRejuvenation, semaglutide weight loss is often a starting point for medical weight loss, especially for patients who are new to these therapies